'Mad Money Lightning Round': Get Some Covidien
To see the full "Mad Money" Recap, please click here.
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Wednesday evening.
Dendreon (DNDN): "Too speculative for me. It's had too big of a move."
VOXX International (VOXX): "If you want to go there, you want Harman International (HAR)."
Pepsico (PEP): "No, that one is played out. You need to sell, sell, sell. Go home." Covidien (COV): "I think you should buy more. That one is in the sweet spot. I want you to stick with Life Technologies (LIFE) as well." People's Bank (PBCT): "This one is like watching paint dry. It doesn't have a catalyst but I do like it long-term." Goldman Sachs (GS): "I think Goldman is going higher. I also like Morgan Stanley (MS). I think it's a buy, buy, buy." Pfizer (PFE): "They have a big buyback. They're not my favorite, but they will be protected by that yield. Don't forget Bristol-Myers Squibb (BMY). I like that one even more." Ford Motor (F): "Ford is doing OK. I think Ford will flatline but better times ahead." Walgreens (WAG): "Walgreen's is in a pickle here. It's good, it's bad, (and) that means we do nothing." Linn Energy (LINE): "Everything is up in the air in oil and gas. I don't mind it but I no longer like it. I'd wait for a bigger yield." Alcoa (AA): "If Europe comes back, they're going to $14, but I've been wrong before on this one." --Written by Scott Rutt in Washington, D.C. To contact the writer of this article, click here: Scott Rutt. Follow TheStreet on Twitter and become a fan on Facebook. To submit a news tip, send an email to: tips@thestreet.com.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV